ROCR Value Based Program Act
- Sponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1]
- Committees
- Ways and Means Committee (primary)
- Last action
- Mar 14, 2025
Bottom line
The bill aims to reform Medicare payments for radiation oncology to incentivize value-based care, improve patient access through transportation support, and ensure payment stability for providers, while explicitly preventing program savings from triggering cuts elsewhere in Medicare.
What it actually does
This bill establishes a new Medicare payment program for radiation oncology services, transitioning from a fee-for-service model to a per-episode case rate payment system. It also creates a statutory exception to civil monetary penalties, allowing providers to offer free or discounted transportation to radiation oncology patients, and exempts the new payment program from Medicare's budget neutrality adjustment requirements.
Proponents argue
Proponents argue that the current Medicare payment system for radiation oncology is flawed, incentivizing greater volumes of care rather than patient-centered, efficient, and high-value treatment. They contend this bill will create stable, unified payments, reduce disparities in care by increasing access, enhance quality through accreditation, encourage the use of state-of-the-art technology, and achieve reasonable spending reductions in Medicare for radiation therapy services.
Opponents contend
Potential opponents might argue that bundled payments could lead to under-treatment or reduced access if the per-episode rates are set too low, particularly for complex cases or in rural areas where providers face unique challenges. The exemption from budget neutrality adjustments could be criticized as a mechanism to increase overall Medicare spending without requiring offsetting cuts, potentially impacting the program's long-term fiscal health.
The bill is moderately detailed, requiring careful reading to understand the new payment mechanisms and definitions, but it is manageable for a dedicated reader within a reasonable timeframe.
Sec. 3, adding new Sec. 1899C(a) to Title XVIII of the Social Security Act
Establishment of Radiation Oncology Case Rate Value Based Payment Program (ROCR Program)
This provision mandates the Secretary of Health and Human Services to establish a new payment system for radiation oncology services under Medicare. Instead of paying for each service individually, providers will receive a single 'per episode' payment for a course of radiation therapy for specific cancer types. This aims to shift incentives towards value-based care, with regulations to be promulgated within one year of enactment.
Supporters argue
Supporters argue this program will create stable, unified payments, reduce disparities, enhance quality, leverage technology, and protect Medicare resources by achieving reasonable spending reductions, as outlined in the bill's findings.
Critics contend
Critics might argue that a rapid shift to bundled payments could disrupt existing practices, particularly for smaller or rural providers, potentially jeopardizing their financial stability and access to care in those areas if implementation is not carefully managed.
Tradeoffs
This provision balances the desire for cost containment and value-based care against potential disruption to current provider operations and concerns about access, especially during the transition period.
Sec. 3, adding new Sec. 1899C(b) to Title XVIII of the Social Security Act
Structure and Timing of Per Episode Payments
This section outlines the financial mechanics of the new payment system. Providers will receive an amount equal to 80 percent of a determined per-episode payment, subject to Medicare Part B deductibles and coinsurance. Payments are split, with half issued prospectively after the first treatment delivery and the remaining half issued either at the scheduled end of treatment or after a set number of days (90 days generally, 30 days for bone/brain metastases).
Sec. 3, adding new Sec. 1899C(d) to Title XVIII of the Social Security Act
National Base Rate Calculation and Adjustment
This provision establishes the foundation for the per-episode payment amounts. It specifies that national base rates for both the professional (physician) and technical (equipment, staff) components of radiation therapy will be based on existing M-Code rates from 2021. These rates will be updated annually for inflation (using different indices for professional and technical components) and re-evaluated every five years, with safeguards against significant reductions (not more than 1% every 5 years).
Sec. 3, adding new Sec. 1899C(g) to Title XVIII of the Social Security Act
Health Equity Achievement in Radiation Therapy Add-On Payment
This provision introduces an additional payment to radiation therapy providers for patients identified with transportation insecurity (using ICD-10 diagnosis code Z59.82). This add-on, starting at $500 per patient per episode of care and increasing annually by $10, is specifically for providing free or discounted transportation services to help beneficiaries access and complete their radiation therapy treatments. Providers must document spending.
Sec. 3, adding new Sec. 1899C(h) to Title XVIII of the Social Security Act
Quality Incentives and Accreditation Requirements
This section links payment adjustments to quality and accreditation. Initially, accredited radiation therapy providers (or those in the process of obtaining it) receive a 1% payment increase (0.25% for limited resource providers). After two years, non-accredited providers face a 2.5% payment reduction. Special provisions are made for 'limited resource' providers and suppliers, who have different accreditation options and are exempt from the payment reduction.
Sec. 3(b), amending Section 1848(q)(1)(C)(ii) of the Social Security Act
Exemption from Merit-Based Incentive Payment System (MIPS)
This provision explicitly exempts radiation therapy providers and suppliers who participate in the new ROCR Program from the existing Merit-Based Incentive Payment System (MIPS). MIPS is another Medicare program that adjusts payments based on performance in quality, cost, and other categories.
Sec. 4, amending Section 1128A of the Social Security Act
New Statutory Exception for Transportation Services
This section creates a new legal 'safe harbor' under the Civil Monetary Penalties Law, allowing eligible entities to provide free or discounted transportation services to radiation oncology patients without fear of violating anti-kickback statutes. This exception comes with strict conditions, such as uniform application, no public marketing, no payment to drivers on a per-beneficiary basis, and limits on patient eligibility (e.g., established patient, within 75-mile radius or rural area).
Sec. 5, amending Sections 1833(t) and 1848(c)(2)(B) of the Social Security Act
Exemption from Budget Neutrality Adjustment Requirements
This critical provision ensures that any cost savings achieved by the new ROCR Program will not be used to offset spending in other parts of Medicare's payment systems (specifically, the hospital outpatient prospective payment system and the physician fee schedule). This means the savings from the ROCR Program will not trigger automatic payment reductions elsewhere in Medicare.
Excludes new radiation therapy technologies or services from being incorporated into the national base rates for bundled payments for a period of 12 years after they are first identified as new technology.
Sec. 3, new Sec. 1899C(d)(2)(D)(i)(I) of Title XVIII of the Social Security Act
Why it matters:This is a technical detail that defines the scope and evolution of the bundled payment model, which is often placed in definitional or operational subsections rather than the main policy statements. It is standard legislative practice for complex payment reforms.
Case for: Proponents might argue that this exclusion allows new technologies to be paid under existing fee-for-service models for a sufficient period, encouraging innovation and adoption without immediately forcing them into a potentially restrictive bundled payment framework before their value and cost are fully understood.
Case against: Critics might contend that a 12-year exclusion delays the integration of potentially beneficial new technologies into the value-based payment model, creating a two-tiered system and potentially hindering the ROCR program's ability to incentivize the most advanced, efficient care.
Estimated impact: This provision could significantly influence the adoption and payment pathways for future radiation therapy innovations for over a decade.
Caps the total number of 'limited resource radiation therapy providers' and 'limited resource radiation therapy suppliers' at 10 percent of the total number of all radiation therapy providers and suppliers.
Sec. 3, new Sec. 1899C(h)(1)(C)(ii) of Title XVIII of the Social Security Act
Why it matters:This is a technical limitation on an exemption category, often placed in definitional sections. It is a common legislative technique to control the scope of special provisions.
Case for: Proponents would argue that this cap ensures the 'limited resource' designation remains targeted to truly vulnerable providers, preventing the exception from becoming too broad and undermining the overall quality and accreditation goals of the program.
Case against: Critics might argue that a rigid 10% cap could exclude deserving providers from 'limited resource' status, particularly if a larger proportion of providers in rural or underserved areas genuinely face significant challenges in meeting accreditation requirements.
Estimated impact: This cap directly limits the number of providers eligible for more flexible accreditation requirements and a smaller initial payment increase, potentially impacting access in certain areas if more than 10% of providers struggle.
Defines 'adaptive radiation therapy planning' by listing specific HCPCS codes (e.g., 77295, 77301) and 'applicable radiation therapy planning trigger code' by listing specific HCPCS codes (e.g., 77261, 77263).
Sec. 3, new Sec. 1899C(j)(1) and (2) of Title XVIII of the Social Security Act
Why it matters:It is standard legislative practice to define technical terms and codes in a dedicated definitions section. While crucial for implementation, these details are not typically part of the high-level policy discussion.
Case for: Proponents argue that explicitly listing these codes provides clarity and certainty for providers regarding which services are covered under 'adaptive radiation therapy planning' and how an episode of care is initiated, ensuring consistent application of the payment model.
Case against: No specific opposition is typically raised against the explicit listing of codes for clarity, though debates might arise during rulemaking if the listed codes are deemed incomplete or inaccurate by stakeholders.
Estimated impact: These codes are fundamental to how providers will bill and be paid for radiation therapy planning and how episodes of care are defined and triggered under the new program.
Specifies that the health equity achievement in radiation therapy add-on payment shall be made when the ICD-10 diagnosis code Z59.82, 'transportation insecurity,' is reported.
Sec. 3, new Sec. 1899C(g)(2)(A) of Title XVIII of the Social Security Act
Why it matters:This is a technical implementation detail, typical for defining eligibility for specific payments based on clinical documentation. It is standard legislative practice to use specific codes for such purposes.
Case for: Proponents argue that using a specific, recognized ICD-10 code for transportation insecurity provides a standardized and objective method for identifying eligible patients, ensuring that the add-on payment is directed to those genuinely facing this barrier to care.
Case against: Some might argue that relying solely on a specific ICD-10 code might not capture all instances of transportation insecurity or could create an incentive for providers to document this code to receive the add-on, potentially leading to inaccurate coding.
Estimated impact: This code is the sole trigger for the health equity add-on payment, directly impacting which patients and providers receive this additional funding.